December 10, 2010
1 min read
Save

Hi-Tech Pharmacal reports 10% rise in second-quarter sales

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

AMITYVILLE, N.Y. — Hi-Tech Pharmacal reported $44.9 million in net sales for the second quarter, representing a 10% increase compared with $40.9 million posted during the second quarter last year, the company announced in a press release.

Net sales of generic pharmaceutical products totaled $36.8 million, up 13% from $32.7 million during the same period last year. Notably, sales of dorzolamide with timolol ophthalmic solution and dorzolamide ophthalmic solution totaled $8.1 million, up from $7.5 million reported during last year's second quarter, according to the release.

Hi-Tech's health care products division, responsible for the marketing of OTC-branded products, posted $3.4 million in second-quarter sales, down 7% from $3.6 million during the same period last year.

Second-quarter net income totaled $10 million, or $0.76 per diluted share, as compared with $7.4 million, or $0.60 per diluted share, for the second quarter a year ago, the release said.